Last updated on April 24, 2014 at 16:01 EDT

Elbit Imaging Announces Receipt of Notice From Bank Hapoalim Reserving All Rights Under Acceleration Notice

July 10, 2013

TEL AVIV, Israel, July 10, 2013 /PRNewswire/ –

Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today,
further to the Company’s announcements on June 6, 2013 and June 20, 2013, that Bank
Hapoalim B.M. has notified the Company that it intends to reserve all of its rights under
the acceleration notice it provided to the Company on June 5, 2013, and that any plan of
arrangement of the Company’s outstanding unsecured financial debt will not derogate from
such rights.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i)
Commercial and Entertainment Centers – Initiation, construction and sale of shopping and
entertainment centers and other mixed-use real property projects, predominantly in the
retail sector, located in Central and Eastern Europe and in India, primarily through its
subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions,
the Company operate and manage commercial and entertainment centers prior to their sale;
(ii) Hotels – Hotel operation and management; (iii) Medical Industries – (a) research and
development, production and marketing of magnetic resonance imaging guided focused
ultrasound treatment equipment and (b) development of stem cell population expansion
technologies and stem cell therapy products for transplantation and regenerative medicine;
(iv) Residential Projects – Initiation, construction and sale of residential projects and
other mixed-use real property projects, predominately residential, located primarily in
India; and (v) Fashion Apparel – Distribution and marketing of fashion apparel and
accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the
intent, belief or current expectations of Elbit Imaging Ltd. and our management about our
business, financial condition, results of operations, and its relationship with its
employees and the condition of our properties. Words such as “believe,” “would,” “expect,”
“intend,” “estimate” and similar expressions are intended to identify forward-looking
statements but are not the exclusive means of identifying such statements. Actual results
may differ materially from those projected, expressed or implied in the forward-looking
statements as a result of various factors including, without limitation, the risk that the
Arrangement will not be approved by all the applicable stakeholders of the Company, the
Court or others, that challenges by third parties or other events outside the control of
the Company could delay the implementation of the Arrangement and result in its
termination, that Bank Hapoalim will not agree to join the Arrangement on the terms
proposed by the Company or at all, that the Company will be unable to refinance the loans
owing to Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and
the factors set forth in our filings with the Securities and Exchange Commission
including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal
year ended December 31, 2012, under the caption “Risk Factors.” Any forward-looking
statements contained in our releases speak only as of the date of such release, and we
caution existing and prospective investors not to place undue reliance on such statements.
Such forward-looking statements do not purport to be predictions of future events or
circumstances, and therefore, there can be no assurance that any forward-looking statement
contained our releases will prove to be accurate. We undertake no obligation to update or
revise any forward-looking statements.

        For Further Information:
        Company Contact:
        Shimon Yitzhaki
        Chairman of the Board of Directors
        Tel: +972-3-608-6048

        Investor Contact:
        Mor Dagan
        Investor Relations
        Tel: +972-3-516-7620

SOURCE Elbit Imaging Ltd.

Source: PR Newswire